The current invention involves a pharmaceutical composition containing a
combination of two active agents. The invention also involves the use of
the combination composition to the preparation of a drug combination
intended to treat, control and prevent type 2 diabetes and other diseases
and conditions that glucose abnormality, including abnormalities in
glucose levels and glucose metabolism, is a component.
